WallStreetZenWallStreetZen

NASDAQ: BCAX
Bicara Therapeutics Inc Stock Ownership - Who owns Bicara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ivan HyepChief Financial Officer2026-01-221,882$3.79
$7.13kBuy
Ryan CohlheppPresident and COO2026-01-223,828$18.10
$69.29kSell
Ivan HyepChief Financial Officer2026-01-221,882$18.15
$34.16kSell
Ryan CohlheppPresident and COO2026-01-15149$18.02
$2.68kSell
Ryan CohlheppPresident and COO2025-12-2625,000$4.44
$110.93kBuy
David RabenChief Medical Officer2025-12-2619,789$3.79
$75.00kBuy
Ivan HyepChief Financial Officer2025-12-229,200$18.31
$168.49kSell
Ivan HyepChief Financial Officer2025-12-229,200$3.79
$34.87kBuy
Claire MazumdarChief Executive Officer2025-12-1629,500$5.45
$160.89kBuy
Ryan CohlheppPresident and COO2025-12-158,000$3.79
$30.32kBuy

1 of 7

BCAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCAX insiders and whales buy or sell their stock.

BCAX Shareholders

What type of owners hold Bicara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP12.70%6,955,993$115.40MInstitution
Kiran Mazumdarshaw11.50%6,297,854$104.48MInsider
Biocon Ltd10.08%5,523,897$91.64MInsider
Siren LLC9.52%5,216,969$86.55MInstitution
Vestal Point Capital LP9.31%5,100,000$84.61MInstitution
Red Tree Management LLC5.79%3,170,509$52.60MInstitution
Tpg GP A LLC5.50%3,010,425$49.94MInstitution
Fmr LLC4.93%2,698,361$44.77MInstitution
Ra Capital Management LP4.84%2,652,575$44.01MInsider
Deep Track Capital LP4.43%2,426,657$40.26MInstitution

1 of 3

BCAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCAX70.36%29.64%Net SellingNet Buying
PVLA57.88%42.12%Net BuyingNet Buying
AVBP78.59%21.41%Net Buying
XNCR72.05%27.95%Net SellingNet Buying
MRVI45.44%54.56%Net BuyingNet Buying
View Top Biotech Stocks

Bicara Therapeutics Stock Ownership FAQ

Who owns Bicara Therapeutics?

Bicara Therapeutics (NASDAQ: BCAX) is owned by 91.63% institutional shareholders, 38.60% Bicara Therapeutics insiders, and 0.00% retail investors. Kiran Mazumdarshaw is the largest individual Bicara Therapeutics shareholder, owning 6.30M shares representing 11.50% of the company. Kiran Mazumdarshaw's Bicara Therapeutics shares are currently valued at $104.48M.

If you're new to stock investing, here's how to buy Bicara Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.